Publication
Regulation Around the World: Open Finance
In this issue of Regulation Around the World we look at how regulators are developing their proposals for Open Finance.
Publication | November 2020
COVID-19 has put a significant focus on the pharmaceutical industry in the development of treatments and a vaccine. Because the pharmaceutical business is a global industry, legal frameworks vary from region to region, especially in the area of intellectual property. The Pharmaceutical Intellectual Property and Competition Law Review examines the complexities of the industry in multiple jurisdictions providing a useful tool for managing global risks.
Norton Rose Fulbright Canada contributed to this publication, providing an overview of the intellectual property laws in Canada and how they interact with Canada’s competition law.
Publication
In this issue of Regulation Around the World we look at how regulators are developing their proposals for Open Finance.
Publication
Canada and the European Union signed a Security and Defence Partnership (SDP), which formalizes a mutual intent to foster closer ties by establishing a framework for dialogue and cooperation across the full security and defence spectrum.
Publication
The Carbon Offsetting and Reduction Scheme for International Aviation (CORSIA) is now half way through its first phase of compliance, while the supporting regulatory frameworks constituting the building blocks for the CORSIA and Article 6 markets are incrementally being cemented in place and the market is developing fair mechanisms for managing key gap risks.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2025